Alcon Inc. Ordinary Shares (ALC) Valuation

Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visi...

Alcon Inc. Ordinary Shares (ALC) currently trades at a P/E ratio of 36.32 (historical range: 34.03–38.15, median: 36.36), placing it at the 45th percentile — near its historical average, P/S ratio of 3.42 (range: 3.21–3.59, 45th percentile — near its historical average), EV/EBITDA of 28.85 (range: 27.20–30.17, 45th percentile).

Alcon Inc. Ordinary Shares appears fairly valued relative to its historical range, with valuation metrics near their median levels.

Historical Valuation Metrics

MetricCurrentMinMedianMaxPercentileAssessment
P/E Ratio36.3234.0336.3638.1545thnear its historical average
P/S Ratio3.423.213.433.5945thnear its historical average
EV/EBITDA28.8527.2028.8830.1745thnear its historical average
Current Price: $71.75
Market Cap: $34.7B
Sector: Healthcare